These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8904143)

  • 21. Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa.
    Schick AE; Angus JC; Coyner KS
    Vet Dermatol; 2007 Apr; 18(2):120-6. PubMed ID: 17355427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prediction model for bacterial etiology in acute exacerbations of COPD.
    Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
    Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibacterial therapy in exacerbation of chronic obstructive bronchitis].
    Sinopal'nikov AI; Fesenko OV
    Klin Med (Mosk); 1998; 76(9):15-20. PubMed ID: 9821367
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
    Mordasini C; Aebischer CC; Schoch OD
    Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of advanced chronic obstructive pulmonary disease.
    Cordova FC; Criner GJ
    Compr Ther; 1997 Jun; 23(6):413-24. PubMed ID: 9239492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
    Burgel PR
    Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic chemoprophylaxis in chronic obstructive lung disease.
    Morgan RB; Hasan FM
    Ariz Med; 1977 Feb; 34(2):94-5. PubMed ID: 836176
    [No Abstract]   [Full Text] [Related]  

  • 31. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pseudomonas spp from hospitals: typing and sensitivity to antibiotics].
    Nazzari C; Mancini C; Brenciaglia MI; Giordano A; Cipriani P
    G Ital Chemioter; 1985; 32(1):203-6. PubMed ID: 3830779
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
    van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
    Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of selected antimicrobial agents against the Pseudmonas pseudomallei infection of mice.
    Grunberg E; Beskid G; Delorenzo WF; Titsworth E
    Am Rev Respir Dis; 1970 Apr; 101(4):623-6. PubMed ID: 5439884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials].
    Garré M; Garo B; Ansart S; Le Berre R
    Med Mal Infect; 2006; 36(11-12):690-6. PubMed ID: 16824719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of antibacterial chemotherapy in the management of chronic bronchial obstructive disease.
    Gialdroni-Grassi G
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):431-6. PubMed ID: 7203719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pseudomonas maltophilia infections].
    Pintér M; Kántor M
    Orv Hetil; 1974 Feb; 115(5):254-5. PubMed ID: 4839507
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacotherapy of chronic obstructive pulmonary disease.
    Borron W; deBoisblanc BP
    J La State Med Soc; 1998 Dec; 150(12):596-600. PubMed ID: 9926698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.